Heard on All Things Considered MICHAELEEN DOUCLEFF This summer, it’s not just athletes who are looking to set world records. Scientists are also trying to break a record — for […]
WCVB5 ABC Virus delared global health emergency A vaccine to protect against the Zika virus is in the works under a research team led by scientists at the Beth Israel […]
WBUR By Jonathan Cain “We hope that this news will electrify and galvanize the vaccine effort against Zika virus,” says Dr. Dan Barouch of Beth Israel Deaconess Medical Center and […]
The Boston Herald Lindsay Kalter A group of researchers at Beth Israel Deaconess Medical Center are testing a vaccine for the Zika virus they say has exceeded expectations in animal […]
- By: Andrew Joseph @DrewQJoseph
Two new experimental vaccines protect mice against the Zika virus, a study out Tuesday shows.
Researchers from governments, academic labs, and biopharma companies have been rushing to develop Zika vaccines since global health experts started warningabout the previously unknown dangers wrought by the mosquito-borne virus, including serious birth defects. Just last week, the Food and Drug Administration approved the first human testing of a Zika vaccine candidate from the company Inovio Pharmaceuticals.
Wired Magazine Eric Niller Rafael de la Barrera reaches into a freezer and pulls out a plastic jug of rusty-red liquid. He wipes frost off the label: “Zika Virus – […]
BIDMC, OHSU to Lead Consortium Exploring Vaccine Candidate and Cure Strategies
BOSTON – With $42 million in funding from the National Institutes of Health, scientists from Beth Israel Deaconess Medical Center (BIDMC) and Oregon Health & Science University (OHSU) will lead a five-year research initiative to advance efforts to cure and prevent HIV/AIDS. Dan Barouch, MD, PhD, Director of the Center for Virology and Vaccine Research at BIDMC, and Louis Picker, MD, Assistant Director of the OHSU Vaccine and Gene Therapy Institute, will lead a consortium of researchers from across the country exploring the mechanisms behind promising new HIV vaccine candidates and potential cure strategies.
- BIDMC Contact: Jennifer Kritz
- Phone: 617-667-7301
- Email: firstname.lastname@example.org
BOSTON – New research in monkeys exposed to SIV, the animal equivalent of HIV, reveals what happens in the very earliest stages of infection, before virus is even detectable in the blood, which is a critical but difficult period to study in humans. The findings, published online today in the journal Cell, have important implications for vaccine development and other strategies to prevent infection.
The Center for Virology and Vaccine Research launched a Volunteer Registry for adults interested in clinical trial participation on December 21st, 2015. The new CVVR Clinical Trials Unit established the […]
amfAR, The Foundation for AIDS Research, announced on July 21st that a CVVR research team has been awarded $2 million to pursue a range of strategies aimed at curing HIV. […]
Sorry, no posts matched your criteria
Center for Virology and Vaccine Research
3 Blackfan Circle
Boston, MA 02115 – USA
CVVR Clinical Trials Unit